Top stocks in focus today: Mphasis, Glenmark Pharma, Patel Engineering

Mphasis’ board approved Rs988.3cr buyback of up to 73.3 lakh shares (3.79%) at Rs1,350 each.

Glenmark Pharma’s partner Elite Pharma gets USFDA acceptance of NDA for Ryaltris.

Patel Engineering won two hydroprojects and tunnel projects order worth Rs2,400cr.

Gujarat High Court dismisses tax demand petition filed by Gujarat Sales Tax department against GAIL, media reports said.

Dhanlaxmi Bank revised its MCLR across various tenors.

GOCL Corporation arm won an order worth Rs203.09cr from Singareni Collieries for supply of explosives and accessories.

Beekay Niryat's board recommended issue of bonus equity shares in the ratio of 1:1.

Daily Intraday Cash Tips